Publication | Closed Access
Evaluation of clinical outcomes and costs based on prescribed dose level of renin-angiotensin-aldosterone system inhibitors.
26
Citations
0
References
2016
Year
HypertensionCardiovascular DiseasePrescribed Dose LevelAntihypertensive TherapyCardiovascular PharmacologyOutcomes ResearchPharmacoeconomicsClinical OutcomesPharmacotherapyMedicineRenin-angiotensin-aldosterone System InhibitorsPharmacoepidemiologyAnesthesiologyEndocrine Hypertension
No additional data available for this publication yet. Check back later!